Efficacy of a Brief Nightmare Treatment for Veterans
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to find out what effects Exposure, Rescripting, and Relaxation Therapy (ERRT) has on nightmares and associated problems in veterans.
| Condition | Intervention |
|---|---|
|
Sleep Disorders PTSD Suicide |
Behavioral: exposure, relaxation, and rescription therapy |
| Study Type: | Interventional |
| Study Design: | Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Efficacy of a Brief Nightmare Treatment for Veterans |
- Trauma Related Nightmare Scale [ Time Frame: pre, one week, two months ] [ Designated as safety issue: No ]measures will be given pre treatment, one week and two months following treatment completion.
- Clinician Administered PTSD Scale [ Time Frame: pre, one week, two months ] [ Designated as safety issue: No ]measures will be given pre treatment, one week and two months following treatment completion.
- Suicide Behaviors Questionnaire [ Time Frame: pre, one week, two months post ] [ Designated as safety issue: No ]measures will be given pre treatment, one week and two months following treatment completion.
| Estimated Enrollment: | 20 |
| Study Start Date: | October 2010 |
| Study Completion Date: | August 2011 |
| Primary Completion Date: | August 2011 (Final data collection date for primary outcome measure) |
-
Behavioral: exposure, relaxation, and rescription therapy
The purpose of the proposed pilot study is to extend previous findings regarding the impact of a brief cognitive behavioral treatment for chronic nightmares by examining the emotional, cognitive, behavioral, and health-related changes following treatment. Experiencing a traumatic event may initiate or exacerbate the occurrence of nightmares. Indeed, sleep disturbance, including nightmares, is considered a hallmark of posttraumatic stress disorder (PTSD). Nightmares have been related to a variety of factors including stress, medications, trauma, and substance use. Among veterans, especially combat veterans or those reporting sexual assaults, symptoms of traumatic stress and nightmares are extremely common. Few studies have investigated the efficacy of nightmare treatment in a veteran population, and the impact of nightmare treatment on suicidal ideation has never been assessed.
Imagery Rehearsal Treatment (IRT) has received increased attention in the past decade for use with chronic nightmares. Studies suggest that the treatment is promising for the reduction of frequency and intensity of chronic nightmares in trauma exposed persons and may have a generalized impact on symptoms of posttraumatic stress disorder and depression and quality/quantity of sleep, although there is mixed evidence for sleep improvement among veterans. The principal investigator has completed two randomized controlled trials of a modified version of IRT, Exposure, Rescripting, and Relaxation Treatment (ERRT) and is currently conducting a third randomized controlled trial (Davis, 2008; Davis & Wright, 2007). The current randomized controlled trial is comparing ERRT to an active treatment (relaxation). Results demonstrated positive treatment response. Although these trials have included some veteran participants, veterans have not been studied as a group using this protocol. The purpose of this prospective study is to conduct a pre- and post-treatment comparison of suicidal ideation and posttraumatic, depressive, and health symptoms in a single group of veterans.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria: veteran/military, 18+ years old, english proficiency, nightmares once per week, exposure to a criterion A traumatic event -
Exclusion Criteria: under 18, psychotic illness, mental retardation, imminent suicidal intent
-
Contacts and Locations| United States, Oklahoma | |
| The University of Tulsa | |
| Tulsa, Oklahoma, United States, 74104 | |
| Principal Investigator: | Noelle Balliett, MA | The University of Tulsa |
More Information
No publications provided
| Responsible Party: | Noelle Balliett, The University of Tulsa |
| ClinicalTrials.gov Identifier: | NCT01220401 History of Changes |
| Other Study ID Numbers: | TU1107 |
| Study First Received: | October 11, 2010 |
| Last Updated: | August 3, 2011 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of Tulsa:
|
Nightmare PTSD Posttraumatic stress disorder |
Suicide Exposure Relaxation Rescription Therapy Sleep |
Additional relevant MeSH terms:
|
Sleep Disorders Parasomnias Stress Disorders, Post-Traumatic Suicide Nervous System Diseases Neurologic Manifestations |
Signs and Symptoms Mental Disorders Stress Disorders, Traumatic Anxiety Disorders Self-Injurious Behavior Behavioral Symptoms |
ClinicalTrials.gov processed this record on May 16, 2013